Copyright Reports & Markets. All rights reserved.

Global and United States Irritable Bowel Syndrome (IBS) Diagnostics Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Irritable Bowel Syndrome (IBS) Diagnostics Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size for the Year 2017-2028
      • 1.2.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size for the Year 2017-2028
    • 1.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Irritable Bowel Syndrome (IBS) Diagnostics in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Irritable Bowel Syndrome (IBS) Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Irritable Bowel Syndrome (IBS) Diagnostics Market Dynamics
      • 1.4.1 Irritable Bowel Syndrome (IBS) Diagnostics Industry Trends
      • 1.4.2 Irritable Bowel Syndrome (IBS) Diagnostics Market Drivers
      • 1.4.3 Irritable Bowel Syndrome (IBS) Diagnostics Market Challenges
      • 1.4.4 Irritable Bowel Syndrome (IBS) Diagnostics Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Irritable Bowel Syndrome (IBS) Diagnostics by Type

    • 2.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Segment by Type
      • 2.1.1 Laboratory Tests
      • 2.1.2 Imaging Tests
    • 2.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017, 2022 & 2028)
    • 2.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2028)
    • 2.4 United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017, 2022 & 2028)
    • 2.5 United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Type (2017-2028)

    3 Irritable Bowel Syndrome (IBS) Diagnostics by Application

    • 3.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Segment by Application
      • 3.1.1 Hospitals and Clinics
      • 3.1.2 Diagnostic Centers
      • 3.1.3 Others
    • 3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2028)
    • 3.4 United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Application (2017-2028)

    4 Global Irritable Bowel Syndrome (IBS) Diagnostics Competitor Landscape by Company

    • 4.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Company
      • 4.1.1 Top Global Irritable Bowel Syndrome (IBS) Diagnostics Companies Ranked by Revenue (2021)
      • 4.1.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Player (2017-2022)
    • 4.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Concentration Ratio (CR)
      • 4.2.1 Irritable Bowel Syndrome (IBS) Diagnostics Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Irritable Bowel Syndrome (IBS) Diagnostics in 2021
      • 4.2.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Irritable Bowel Syndrome (IBS) Diagnostics Headquarters, Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Headquarters and Area Served
      • 4.3.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Companies Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Irritable Bowel Syndrome (IBS) Diagnostics Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Company
      • 4.5.1 Top Irritable Bowel Syndrome (IBS) Diagnostics Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Irritable Bowel Syndrome (IBS) Diagnostics Revenue by Players (2020, 2021 & 2022)

    5 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region

    • 5.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2017-2028)
      • 5.2.1 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region: 2017-2022
      • 5.2.2 Global Irritable Bowel Syndrome (IBS) Diagnostics Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth 2017-2028
      • 6.1.2 North America Irritable Bowel Syndrome (IBS) Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Irritable Bowel Syndrome (IBS) Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Irritable Bowel Syndrome (IBS) Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Commonwealth Diagnostics International
      • 7.1.1 Commonwealth Diagnostics International Company Details
      • 7.1.2 Commonwealth Diagnostics International Business Overview
      • 7.1.3 Commonwealth Diagnostics International Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.1.4 Commonwealth Diagnostics International Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.1.5 Commonwealth Diagnostics International Recent Development
    • 7.2 Genova Diagnostics
      • 7.2.1 Genova Diagnostics Company Details
      • 7.2.2 Genova Diagnostics Business Overview
      • 7.2.3 Genova Diagnostics Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.2.4 Genova Diagnostics Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.2.5 Genova Diagnostics Recent Development
    • 7.3 Gemelli Biotech
      • 7.3.1 Gemelli Biotech Company Details
      • 7.3.2 Gemelli Biotech Business Overview
      • 7.3.3 Gemelli Biotech Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.3.4 Gemelli Biotech Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.3.5 Gemelli Biotech Recent Development
    • 7.4 Prometheus Laboratories
      • 7.4.1 Prometheus Laboratories Company Details
      • 7.4.2 Prometheus Laboratories Business Overview
      • 7.4.3 Prometheus Laboratories Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.4.4 Prometheus Laboratories Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.4.5 Prometheus Laboratories Recent Development
    • 7.5 Inova Diagnostics, Inc.
      • 7.5.1 Inova Diagnostics, Inc. Company Details
      • 7.5.2 Inova Diagnostics, Inc. Business Overview
      • 7.5.3 Inova Diagnostics, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.5.4 Inova Diagnostics, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.5.5 Inova Diagnostics, Inc. Recent Development
    • 7.6 Biohit Oyj
      • 7.6.1 Biohit Oyj Company Details
      • 7.6.2 Biohit Oyj Business Overview
      • 7.6.3 Biohit Oyj Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.6.4 Biohit Oyj Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.6.5 Biohit Oyj Recent Development
    • 7.7 Aerodiagnostics, LLC.
      • 7.7.1 Aerodiagnostics, LLC. Company Details
      • 7.7.2 Aerodiagnostics, LLC. Business Overview
      • 7.7.3 Aerodiagnostics, LLC. Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.7.4 Aerodiagnostics, LLC. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.7.5 Aerodiagnostics, LLC. Recent Development
    • 7.8 Metabolic Solutions, Inc.
      • 7.8.1 Metabolic Solutions, Inc. Company Details
      • 7.8.2 Metabolic Solutions, Inc. Business Overview
      • 7.8.3 Metabolic Solutions, Inc. Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.8.4 Metabolic Solutions, Inc. Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.8.5 Metabolic Solutions, Inc. Recent Development
    • 7.9 Sysmex Corporation
      • 7.9.1 Sysmex Corporation Company Details
      • 7.9.2 Sysmex Corporation Business Overview
      • 7.9.3 Sysmex Corporation Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.9.4 Sysmex Corporation Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.9.5 Sysmex Corporation Recent Development
    • 7.10 Buhlmann Laboratories AG
      • 7.10.1 Buhlmann Laboratories AG Company Details
      • 7.10.2 Buhlmann Laboratories AG Business Overview
      • 7.10.3 Buhlmann Laboratories AG Irritable Bowel Syndrome (IBS) Diagnostics Introduction
      • 7.10.4 Buhlmann Laboratories AG Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022)
      • 7.10.5 Buhlmann Laboratories AG Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:

      Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests. However, IBS is majorly diagnosed by lactose intolerance tests, breath test for bacterial overgrowth, blood test, and stool test. The tests are done based on symptoms such as constipation-predominant, diarrhea-predominant, or mixed. It can also detect by various imaging tests such as CT Scan or X-ray, upper endoscopy, and colonoscopy.
      Market Analysis and Insights: Global and United States Irritable Bowel Syndrome (IBS) Diagnostics Market
      This report focuses on global and United States Irritable Bowel Syndrome (IBS) Diagnostics market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global Irritable Bowel Syndrome (IBS) Diagnostics market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Laboratory Tests accounting for % of the Irritable Bowel Syndrome (IBS) Diagnostics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospitals and Clinics was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the Irritable Bowel Syndrome (IBS) Diagnostics market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
      Global Irritable Bowel Syndrome (IBS) Diagnostics Scope and Market Size
      Irritable Bowel Syndrome (IBS) Diagnostics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Irritable Bowel Syndrome (IBS) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the Irritable Bowel Syndrome (IBS) Diagnostics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the Irritable Bowel Syndrome (IBS) Diagnostics market is segmented into
      Laboratory Tests
      Imaging Tests
      Segment by Application, the Irritable Bowel Syndrome (IBS) Diagnostics market is segmented into
      Hospitals and Clinics
      Diagnostic Centers
      Others
      Regional and Country-level Analysis
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and Irritable Bowel Syndrome (IBS) Diagnostics Market Share Analysis
      Irritable Bowel Syndrome (IBS) Diagnostics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Irritable Bowel Syndrome (IBS) Diagnostics business, the date to enter into the Irritable Bowel Syndrome (IBS) Diagnostics market, Revenue in Irritable Bowel Syndrome (IBS) Diagnostics Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
      The major vendors covered:
      Commonwealth Diagnostics International
      Genova Diagnostics
      Gemelli Biotech
      Prometheus Laboratories
      Inova Diagnostics, Inc.
      Biohit Oyj
      Aerodiagnostics, LLC.
      Metabolic Solutions, Inc.
      Sysmex Corporation
      Buhlmann Laboratories AG
      Buy now